Dehydroepiandrosterone, epiandrosterone and synthetic derivatives inhibit Junin virus replication in vitro

Virus Research

Volumn 135, Issue 2, 2008, Pages 203-212

  Acosta, Eliana G ^a   Bruttomesso, Andrea C ^a   Bisceglia, Juan A ^a   Wachsman, Mónica B ^a   Galagovsky, Lydia R ^a   Castilla, Viviana ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antiviral activity; Arenavirus; Dehydroepiandrosterone; DHEA; Junin virus; Steroid

Indexed keywords

17 OXO 5ALPHA ANDROSTAN 3BETA YL ACETATE; 17 OXO 5ALPHA ANDROSTAN 3BETA,16BETA YL DIACETATE; 17 OXO 5ALPHA ANDROSTAN 5 EN 3BETA,16ALPHA YL DIACETATE; 17 OXOANDROST 5 EN 3BETA YL ACETATE; 17 OXOANDROST 5 EN 3BETA,16ALPHA YL DIACETATE; 17 OXOANDROST 5 EN 3BETA,16BETA YL DIACETATE; 17,17 ETHYLENDIOXY 3BETA ANDROSTANOL; 17,17 ETHYLENDIOXY 3BETA ANDROSTANYL ACETATE; 17,17 ETHYLENDIOXY 3BETA,6ALPHA ANDROSTANEDIOL; 17,17 ETHYLENDIOXYANDROST 15 EN 3BETA OL; 17,17 ETHYLENDIOXYANDROST 5 EN 3BETA OL; 3BETA 6ALPHA DIHYDROXY 17 ANDROSTANONE; 3BETA HYDROXYANDROST 15 EN 17 ONE; 3BETA,15ALPHA DIHYDROXY 5ALPHA ANDROSTAN 17 ONE; 3BETA,15BETA DIHYDROXY 5ALPHA ANDROSTAN 17 ONE; 3BETA,16ALPHA DIHYDROXY 5ALPHA ANDROSTAN 17 ONE; EPIANDROSTERONE; GLYCOPROTEIN G1; PRASTERONE; RIBAVIRIN; VIRUS PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARENAVIRUS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; IN VITRO STUDY; JUNIN VIRUS; NONHUMAN; PICHINDE ARENAVIRUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VERO CELL; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANDROSTERONE; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DEHYDROEPIANDROSTERONE; JUNIN VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VERO CELLS; VIRAL PROTEINS; VIRUS REPLICATION;

ARENAVIRIDAE; ARENAVIRUS; JUNIN VIRUS; PICHINDE VIRUS; TACARIBE VIRUS;

EID: 46149094611     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2008.03.014     Document Type: Article

References (31)

1. Bradley W., Graus L., Good R., and Day N. Dehydroepiandrosterone inhibits replication of feline immunodeficiency virus in chronically infected cells. Vet. Immunol. Immunopathol. 46 (1995) 159-168
2. Castilla V., Mersich S.E., Candurra N.A., and Damonte E.B. The entry of Junin virus into Vero cells. Arch. Virol. 136 (1994) 363-374
3. Castilla V., Larzabal M., Sgalippa N., Wachsman M., and Coto C. Antiviral mode of action of a synthetic brassinosteroid against Junin virus replication. Antiviral Res. 68 (2005) 88-95
4. Chang C., Ou Y., Raung S., and Chen C. Antiviral effect of dehydroepiandrosterone on Japanese encephalitis virus infection. J. Gen. Virol. 86 (2005) 2513-2523
5. Cooray S. The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J. Gen. Virol. 85 (2004) 1065-1076
6. Damonte E., and García C. Perspectives for the therapy against arenavirus infections. In: Torrence P.F. (Ed). Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats (2005), John Wiley & Sons Inc., New Jersey 115-138
7. De Clercq E. Antiviral drugs in current clinical use. J. Clin. Virol. 30 (2004) 115-133
8. Defaye G., and Chambaz E. Synthesis of 15β-hydroxylated derivatives of dehydroisoandrosterone and isoandrosterone. Tetrahedron Lett. 19 (1978) 3849-3850
9. Diallo K., Loemba H., Oliveira M., Mavoungou D., and Wainberg M. Inhibition of human immunodeficiency virus type-1 (HIV-1) replication by immunor (IM28), a new analog of dehydroepiandrosterone. Nucleosids Nucleotides Nucleic Acids 19 (2000) 2019-2024
10. Enria D.A., and Maiztegui J.I. Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res. 23 (1994) 23-31
11. Garrido Santos G.A., Murray A.P., Pujol C.A., Damonte E.B., and Maier M.S. Synthesis and antiviral activity of sulphated and acetylated derivatives of 2β,3α-dihydroxy-5α cholestane. Steroids 68 (2003) 125-132
12. Henderson E., Schwartz A., Pashko L., Abou-Gharbia M., and Swern D. Dehydroepiandrosterone and 16 alpha-bromo-epiandrosterone: inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes. Carcinogenesis 2 (1981) 683-686
13. Iwasaki M. The Reformatsky reaction of 17-ketosteroids with ethyl α-bromopropionate. Steroids 9 (1967) 373-386
14. Jiang Y., Miyazaki T., Honda A., Hirayama T., Yoshida S., Tanaka N., and Matsuzaki Y. Apoptosis and inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway in the anti-proliferative actions of dehydroepiandreosterone. J. Gastoenterol. 40 (2005) 460-497
15. Johnson W.S., Gastambide B., and Pappo R. The action of lead tetra-acetate on an enol acetate. Their interconversion and rearrangement. J. Am. Chem. Soc. 79 (1957) 1991-1994
16. Labrie F., Luu-The V., Labrie C., Bélanger A., Simard J., Lin S., and Pelletier G. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr. Rev. 24 (2003) 152-182
17. i protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology 148 (2007) 3068-3076
18. Loria R.M. Immune up-regulation and tumor apoptosis by androstene steroids. Steroids 67 (2002) 953-966
19. Mavoungou D., Poaty-Mavoungoun V., Akoume M., and Mavoungou B. Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein mediated cell-cell fusion by immunor (IM28). Virol. J. 2 (2005) 2-9
20. McCormick J., King I., Webb P., Scribner C., Craven R., Johnson K., Elliot L., and Belmont-Williams R. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314 (1986) 20-26
21. Nawata H., Yanase T., Goto K., Okabe T., and Ashida K. Mechanism of action of antiaging DHEA-S and the replacement of DHEA-S. Mech. Ageing Dev. 123 (2002) 1101-1106
22. Numazawa M., and Osawa Y. Improved synthesis of 16 alpha-hydroxylated androgens: intermediates of estriol formation in pregnancy. Steroids 32 (1978) 519-527
23. Numazawa M., and Nagaoka M. Stereospecific synthesis of 16 α-hydroxy-17-oxo steroids by controlled alkaline hydrolysis of corresponding 16-bromo-17-ketones and its reaction mechanism. J. Org. Chem. 47 (1982) 4024-4029
24. Ruiz-Jarabo C., Ly C., Domingo E., and de la Torre J. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308 (2003) 37-47
25. Sánchez A., Pifat D., Kenyon R., Peters C., McCormick J., and Kiley M. Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J. Gen. Virol. 70 (1989) 1125-1132
26. Shin Y., Liu Q., Tikoo S.K., Babiuk L.A., and Zhou Y. Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation. J. Gen. Virol. 88 (2007) 942-950
27. Sondheimer F., Burstein S., and Mechoulam R. Syntheses in the cardiac aglycone field III. The conversion of a 14α- to a 14β-hydroxy group in the androstane series. The ultraviolet spectra of Δ15-androsten-17-ones. J. Am. Chem. Soc. 82 (1960) 3209-3212
28. Tortorici M., Albariño C., Posik D.M., Ghiringhelli P., Lozano M., Rivera Pomar R., and Romanowsky V. Arenavirus nucleocapsid protein displays a transcriptional antitermination activity in vivo. Virus Res. 73 (2001) 41-55
29. Wachsman M., López E., Ramírez J., Galagovsky L., and Coto C. Antiviral effect of brassinosteroids against herpes virus and arenaviruses. Antivir. Chem. Chemother. 11 (2000) 71-77
30. Wachsman M., Ramírez J., Talarico L., Galagovsky L., and Coto C. Antiviral activity of natural and synthetic brassinosteroids. Curr. Med. Chem. 3 (2004) 163-179
31. Yoshida S., Honda A., Matsuzaki Y., Fukushima S., Tanaka N., Takagiwa A., Fujimoto Y., Miyazaki H., and Salen G. Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines. Steroids 68 (2003) 73-83